http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104894070-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate | 2015-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104894070-B |
| titleOfInvention | A kind of tissue engineering devices that monitoring tumour develops |
| abstract | A kind of monitoring tumour develops the building of tissue engineering devices, its method is: reporting system of the building synergic monitoring based on metabolism and inflammation, it specifically includes, UCP1 promoter drives the Reporter gene vector of the viral vectors of VP16- Δ PPARg (128-229aa) expression, the viral vectors of mCMV-STAT3- binding member promoter, fusion driving Gal4BD- Δ PGC1a (170-350aa) expression and UAS/Gal4 driving EGFP expression.Using the methods of virus infection, above-mentioned three kinds of expression vectors transfection simultaneously to fat stem cell etc. can be divided into the seed cell of fat cell, then after the cell of directed differentiation being further loaded onto tissue engineering bracket after stem cell progress vitro differentiation induction, it transplants in subcutaneous, regenerates fat；Expression intensity by monitoring EGFP monitors the degree of body inflammatory and fever, predicts tumour evolving trend. |
| priorityDate | 2015-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.